Artiva Biotherapeutics (ARTV) Cash From Operations

Annual CFO

-$47.43 M
+$3.40 M+6.69%

December 31, 2023


Summary


Performance

ARTV Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

Quarterly CFO

-$11.61 M
+$2.07 M+15.16%

September 30, 2024


Summary


Performance

ARTV Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

TTM CFO

-$51.06 M
-$863.00 K-1.72%

September 30, 2024


Summary


Performance

ARTV TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ARTV Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.7%0.0%0.0%
3 y3 years-250.3%0.0%0.0%
5 y5 years-0.0%0.0%

ARTV Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-209.9%+6.7%-20.1%+23.0%-428.3%at low
5 y5-year-250.3%+6.7%-236.9%+23.0%-702.1%at low
alltimeall time-250.3%+6.7%-236.9%+23.0%-702.1%at low

Artiva Biotherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.61 M(-15.2%)
-$51.06 M(+1.7%)
Jun 2024
-
-$13.69 M(-9.3%)
-$50.19 M(+4.0%)
Mar 2024
-
-$15.09 M(+41.3%)
-$48.27 M(+1.8%)
Dec 2023
-$47.43 M
-$10.68 M(-0.7%)
-$47.43 M(+29.0%)
Sep 2023
-
-$10.75 M(-8.6%)
-$36.76 M(+41.3%)
Jun 2023
-
-$11.76 M(-17.4%)
-$26.01 M(+82.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$14.24 M(+47.4%)
-$14.24 M(+47.4%)
Dec 2022
-$50.83 M(+232.1%)
-
-
Mar 2022
-
-$9.66 M(-214.0%)
-$9.66 M(-214.0%)
Dec 2021
-$15.30 M(+13.0%)
-
-
Mar 2021
-
$8.48 M
$8.48 M
Dec 2020
-$13.54 M
-
-

FAQ

  • What is Artiva Biotherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics annual CFO year-on-year change?
  • What is Artiva Biotherapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics quarterly CFO year-on-year change?
  • What is Artiva Biotherapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics TTM CFO year-on-year change?

What is Artiva Biotherapeutics annual cash flow from operations?

The current annual CFO of ARTV is -$47.43 M

What is the all time high annual CFO for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high annual cash flow from operations is -$13.54 M

What is Artiva Biotherapeutics annual CFO year-on-year change?

Over the past year, ARTV annual cash flow from operations has changed by +$3.40 M (+6.69%)

What is Artiva Biotherapeutics quarterly cash flow from operations?

The current quarterly CFO of ARTV is -$11.61 M

What is the all time high quarterly CFO for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high quarterly cash flow from operations is $8.48 M

What is Artiva Biotherapeutics quarterly CFO year-on-year change?

Over the past year, ARTV quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Artiva Biotherapeutics TTM cash flow from operations?

The current TTM CFO of ARTV is -$51.06 M

What is the all time high TTM CFO for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high TTM cash flow from operations is $8.48 M

What is Artiva Biotherapeutics TTM CFO year-on-year change?

Over the past year, ARTV TTM cash flow from operations has changed by $0.00 (0.00%)